Skip to Content

Join the 'Vasomotor Rhinitis' group to help and get support from people like you.

Vasomotor Rhinitis News

Air Pollution May Raise Risk of Type 2 Diabetes

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – High levels of air pollution may increase some Hispanic children's risk of type 2 diabetes, a new study suggests. "Exposure to heightened air pollution during childhood increases the risk for Hispanic children to become obese and, independent of that, to also develop type 2 diabetes," said study corresponding author Michael Goran. He is co-director of the University of ...

Clean Pools Can Still Pose Health Hazards

Posted 2 Jun 2016 by Drugs.com

THURSDAY, June 2, 2016 – Nothing seems better on a hot day than hopping into a cool swimming pool. But, new research might prompt you to shower first and make sure your kids don't pee in the water. Researchers from the University of South Carolina report that the disinfectants used to keep pools clean can create dangerous disinfection byproducts (DBPs) when combined with sweat, personal care ...

Smog's Health Effects Persist for Decades, Study Finds

Posted 10 Feb 2016 by Drugs.com

TUESDAY, Feb. 9, 2016 – Air pollution can increase the risk of premature death, even decades later, one of the longest running air pollution studies suggests. British scientists found the negative health effects of air pollution – such as a higher risk of lung and heart disease – can persist for more than 30 years. The study authors suggested that more research into the long-term health ...

Smog Threatens Visitors to U.S. National Parks: Report

Posted 31 Jul 2015 by Drugs.com

FRIDAY, July 31, 2015 – Air pollution afflicts many national parks across the United States, a new study suggests. Air quality in some of the parks is as bad or worse than in some major cities because of pollution from sources such as coal-fired power stations, the National Parks Conservation Association says in a new report. "Our parks remain under threat from air pollution, harming visitors' ...

FDA Approves Tris Pharma's New Drug Application for Karbinal ER

Posted 3 Apr 2013 by Drugs.com

MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5mL, the first sustained-release histamine ...

Ask a Question

Further Information

Related Condition Support Groups

Rhinitis

Related Drug Support Groups

Pediatex, Palgic, carbinoxamine, Pediox, Carboxine, Cordron NR, Pediatex 12, Histex CT, Histex IE, Histex PD, Arbinoxa, Karbinal ER, Ryvent